Activist 13D/13G Filings - Venrock Healthcare Capital Partners III L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-08-19
4:15 pm
Purchase
13GTENAX THERAPEUTICS INC PAR
TENX
Venrock Healthcare Capital Partners III L.P.355,224
9.99%
355,224increase
(New Position)
View
2024-08-01
4:18 pm
Purchase
13GArtiva Biotherapeutics Inc.
ARTV
Venrock Healthcare Capital Partners III L.P.1,609,569
6.9%
1,609,569increase
(New Position)
View
2024-07-25
8:48 pm
Purchase
13GCASI Pharmaceuticals Inc.
CASI
Venrock Healthcare Capital Partners III L.P.1,507,040
9.99%
1,507,040increase
(New Position)
View
2024-06-24
4:15 pm
Purchase
13GPERCEPTIVE CAP SOLUTIONS CORP
PCSC
Venrock Healthcare Capital Partners III L.P.750,000
8.4%
750,000increase
(New Position)
View
2024-05-31
4:18 pm
Purchase
13GERASCA INC
ERAS
Venrock Healthcare Capital Partners III L.P.16,216,216
6.5%
16,216,216increase
(New Position)
View
2024-05-02
4:16 pm
Purchase
13GZURA BIO LTD
ZURA
Venrock Healthcare Capital Partners III L.P.6,399,619
9.99%
6,399,619increase
(New Position)
View
2024-04-29
7:28 pm
Purchase
13GORUKA THERAPEUTICS INC
ORKA
Venrock Healthcare Capital Partners III L.P.754,669
5.2%
754,669increase
(New Position)
View
2024-04-01
6:21 pm
Purchase
13GAQUESTIVE THERAPEUTICS INC
AQST
Venrock Healthcare Capital Partners III L.P.5,555,555
6.5%
5,555,555increase
(New Position)
View
2024-03-04
4:16 pm
Purchase
13GCentury Therapeutics Inc.
IPSC
Venrock Healthcare Capital Partners III L.P.3,405,133
5.4%
3,405,133increase
(New Position)
View
2024-02-26
4:15 pm
Purchase
13GenGene Holdings Inc.
ENGN
Venrock Healthcare Capital Partners III L.P.2,565,841
5.9%
2,565,841increase
(New Position)
View
2024-02-14
9:20 pm
Purchase
13GAPPLIED THERAPEUTICS INC
APLT
Venrock Healthcare Capital Partners III L.P.7,877,817
9.99%
2,080,232increase
(+35.88%)
View
2024-02-14
9:13 pm
Unchanged
13GAVALO THERAPEUTICS INC PAR
AVTX
Venrock Healthcare Capital Partners III L.P.0
0%
0
(Unchanged)
View
2024-02-14
8:56 pm
Purchase
13GMersana Therapeutics Inc.
MRSN
Venrock Healthcare Capital Partners III L.P.11,328,000
9.4%
1,650,000increase
(+17.05%)
View
2024-02-14
8:56 pm
Sale
13GMILESTONE PHARMACEUTICALS INC
MIST
Venrock Healthcare Capital Partners III L.P.925,048
2.8%
-1,283,764decrease
(-58.12%)
View
2024-02-14
8:53 pm
Purchase
13GCABALETTA BIO INC
CABA
Venrock Healthcare Capital Partners III L.P.2,563,952
6.4%
668,667increase
(+35.28%)
View
2024-02-14
8:53 pm
Purchase
13GEnliven Therapeutics Inc.
ELVN
Venrock Healthcare Capital Partners III L.P.2,954,902
7.2%
740,760increase
(+33.46%)
View
2024-02-14
8:52 pm
Purchase
13GKALVISTA PHARMACEUTICALS INC C
KALV
Venrock Healthcare Capital Partners III L.P.4,824,731
14%
1,251,017increase
(+35.01%)
View
2024-02-14
8:51 pm
Purchase
13G4D MOLECULAR THERAPEUTICS INC.
FDMT
Venrock Healthcare Capital Partners III L.P.4,400,000
8.9%
1,512,483increase
(+52.38%)
View
2024-02-14
8:47 pm
Purchase
13GSpyre Therapeutics Inc.
SYRE
Venrock Healthcare Capital Partners III L.P.3,734,514
9.99%
3,734,514increase
(New Position)
View
2024-02-14
8:45 pm
Purchase
13GPRAXIS PRECISION MEDICINES INC
PRAX
Venrock Healthcare Capital Partners III L.P.823,626
8.9%
823,626increase
(New Position)
View
Goto 0, 1, 2, 3, Next